Woman does yoga outside while wearing an insulin pump.


GET STARTED WITH PUMP TECHNOLOGY

Our insulin pumps offer advanced protection and innovative design features to help keep you in range.
SEE ALL INSULIN PUMPS
NEWS: COVID-19 Updates
LEARN MORE
VIEW PRODUCTS
GET SUPPORT
JOIN COMMUNITY
FIND OUT MORE

DISCOVER MINIMEDTM 670G

The first insulin pump system that constantly self-adjusts to help keep glucose levels in target range, automatically.†

DISCOVER MiniMed 670G
Young girl holds tennis racket and ball while wearing an insulin pump.

NEW GUARDIANTM CONNECT

Introducing our smart CGM system that predicts glucose lows and highs up to an hour in advance.*

SEE GUARDIAN CONNECT

ORDER DIABETES SUPPLIES

The Medtronic eShop offers 2-day shipping on all orders.

ORDER SUPPLIES

GET PRODUCT SUPPORT

Find in-depth product instructions, downloads, and other useful tools.

FIND SUPPORT

SIGN UP FOR CARELINKTM PERSONAL

Spot highs and lows and discover patterns with our free web-based software.

GET CARELINK
Backside view of man after he shoots a basketball.

READ PATIENT STORIES

Learn more about our products from the people who use them.

READ STORIES
*

Smart CGM predicts future high and low sensor glucose events up to 60 minutes in advance and provides access to additional algorithms and insights that can inform users of clinically relevant glucose patterns.

†

Some user interaction required

  • Do not use the Guardian Connect System for pediatric patients until you have thoroughly reviewed (with your Healthcare Professional), the system alert performance in the Guardian Connect Application User Guide and the sensor accuracy performance in the Guardian Sensor (3) Performance document. Discuss with your Healthcare Professional how to best set up your Guardian Connect System alerts to reduce the risk of missing low blood glucose or high blood glucose events.
  • In the pediatric clinical study (3-18 years of age), larger differences were observed between the Guardian Connect System and actual blood glucose values compared to those differences observed in the adolescent/adult clinical study (14-75 years of age), particularly at low glucose levels.
  • In the pediatric clinical study, a significant percentage of low glucose events were not detected by the Guardian Connect System. Do not rely solely on the Guardian Connect System alerts to detect low glucose.
  • In the pediatric clinical study, the Guardian Connect System triggered a high percentage of false low glucose and false high glucose alerts. The Guardian Connect System is not intended to make therapy adjustments: always check your capillary blood glucose before making therapy adjustments.
  • In the pediatric clinical study, enabling the ‘Alert Before Low’ and ‘Alert Before High’ predicted alerts significantly reduced the percentage of missed low blood glucose and missed high blood glucose events, but also significantly increased the percentage of false low glucose and false high glucose alerts. Do not ignore alerts from your Guardian Connect System. Always follow your treatment instructions from your Healthcare Professional when responding to an alert from your Guardian Connect System.

Information on this site should not be used as a substitute for talking with your doctor. Always talk with your doctor about diagnosis and treatment information.